Applied Short Term Debt from 2010 to 2024

APDN Stock  USD 0.60  0.01  1.64%   
Applied DNA Short Term Debt yearly trend continues to be very stable with very little volatility. Short Term Debt is likely to drop to about 426.3 K. During the period from 2010 to 2024, Applied DNA Short Term Debt quarterly data regression pattern had sample variance of 845.5 B and median of  498,598. View All Fundamentals
 
Short Term Debt  
First Reported
2003-12-31
Previous Quarter
510 K
Current Value
521.7 K
Quarterly Volatility
1.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Applied DNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied main balance sheet or income statement drivers, such as Other Operating Expenses of 14 M, Total Operating Expenses of 12.7 M or Depreciation And Amortization of 764.5 K, as well as many exotic indicators such as Price To Sales Ratio of 1.29, Dividend Yield of 0.0 or PTB Ratio of 52.8 K. Applied financial statements analysis is a perfect complement when working with Applied DNA Valuation or Volatility modules.
  
This module can also supplement Applied DNA's financial leverage analysis and stock options assessment as well as various Applied DNA Technical models . Check out the analysis of Applied DNA Correlation against competitors.

Latest Applied DNA's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Applied DNA Sciences over the last few years. It is Applied DNA's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied DNA's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

Applied Short Term Debt Regression Statistics

Arithmetic Mean947,744
Geometric Mean0.00
Coefficient Of Variation97.02
Mean Deviation821,182
Median498,598
Standard Deviation919,532
Sample Variance845.5B
Range2.8M
R-Value(0.51)
Mean Square Error673.5B
R-Squared0.26
Significance0.05
Slope(104,909)
Total Sum of Squares11.8T

Applied Short Term Debt History

2024426.3 K
2023448.7 K
2020498.6 K
20181.8 M
2014null
20111.8 M
20102.8 M

About Applied DNA Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Applied DNA income statement, its balance sheet, and the statement of cash flows. Applied DNA investors use historical funamental indicators, such as Applied DNA's Short Term Debt, to determine how well the company is positioned to perform in the future. Although Applied DNA investors may use each financial statement separately, they are all related. The changes in Applied DNA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Applied DNA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Applied DNA Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Applied DNA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt448.7 K426.3 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out the analysis of Applied DNA Correlation against competitors.
Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Applied Stock analysis

When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(17.63)
Revenue Per Share
7.666
Quarterly Revenue Growth
(0.79)
Return On Assets
(0.64)
Return On Equity
(2.52)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.